scholarly journals Production and characterization of antibody against Opisthorchis viverrini via phage display and molecular simulation

PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0248887
Author(s):  
Sitthinon Siripanthong ◽  
Anchalee Techasen ◽  
Chanin Nantasenamat ◽  
Aijaz Ahmad Malik ◽  
Paiboon Sithithaworn ◽  
...  

In this study, a key issue to be addressed is the safe disposal of hybridoma instability. Hybridoma technology was used to produce anti–O. viverrini monoclonal antibody. Previous studies have shown that antibody production via antibody phage display can sustain the hybridoma technique. This paper presents the utility of antibody phage display technology for producing the phage displayed KKU505 Fab fragment and using experiments in concomitant with molecular simulation for characterization. The phage displayed KKU505 Fab fragment and characterization were successfully carried out. The KKU505 hybridoma cell line producing anti–O. viverrini antibody predicted to bind to myosin was used to synthesize cDNA so as to amplify the heavy chain and the light chain sequences. The KKU505 displayed phage was constructed and characterized by a molecular modeling in which the KKU505 Fab fragment and -O. viverrini myosin head were docked computationally and it is assumed that the Fab fragment was specific to -O. viverrini on the basis of mass spectrometry and Western blot. This complex interaction was confirmed by molecular simulation. Furthermore, the KKU505 displayed phage was validated using indirect enzyme-linked immunosorbent assays (ELISA) and immunohistochemistry. It is worthy to note that ELISA and immunohistochemistry results confirmed that the Fab fragment was specific to the -O. viverrini antigen. Results indicated that the approach presented herein can generate anti–O. viverrini antibody via the phage display technology. This study integrates the use of phage display technology together with molecular simulation for further development of monoclonal antibody production. Furthermore, the presented work has profound implications for antibody production, particularly by solving the problem of hybridoma stability issues.

2009 ◽  
Vol 14 (3) ◽  
pp. 282-293 ◽  
Author(s):  
Laura Turunen ◽  
Kristiina Takkinen ◽  
Hans Söderlund ◽  
Timo Pulli

Antibody phage display technology is well established and widely used for selecting specific antibodies against desired targets. Using conventional manual methods, it is laborious to perform multiple selections with different antigens simultaneously. Furthermore, manual screening of the positive clones requires much effort. The authors describe optimized and automated procedures of these processes using a magnetic bead processor for the selection and a robotic station for the screening step. Both steps are performed in a 96-well microplate format. In addition, adopting the antibody phage display technology to automated platform polyethylene glycol precipitation of the enriched phage pool was unnecessary. For screening, an enzyme-linked immunosorbent assay protocol suitable for a robotic station was developed. This system was set up using human γ-globulin as a model antigen to select antibodies from a VTT naive human single-chain antibody (scFv) library. In total, 161 γ-globulin-selected clones were screened, and according to fingerprinting analysis, 9 of the 13 analyzed clones were different. The system was further tested using testosterone bovine serum albumin (BSA) and β-estradiol-BSA as antigens with the same library. In total, 1536 clones were screened from 4 rounds of selection with both antigens, and 29 different testosterone-BSA and 23 β-estradiol-BSA binding clones were found and verified by sequencing. This automated antibody phage display procedure increases the throughput of generating wide panels of target-binding antibody candidates and allows the selection and screening of antibodies against several different targets in parallel with high efficiency. ( Journal of Biomolecular Screening 2009:282-293)


2012 ◽  
Vol 50 (No. 6) ◽  
pp. 231-252 ◽  
Author(s):  
J. Brichta ◽  
M. Hnilova ◽  
T. Viskovic

Production of antibodies has been revolutionized by the development of modern molecular biology methods for the expression of recombinant DNA. Phage display technology represents one of the most powerful tools for production and selection of recombinant antibodies and has been recognized as a valuable alternative way for the preparation of antibodies of a desired specificity. In comparison to poly- and monoclonal antibodies, recombinant antibodies using the phage display technology can be prepared faster, in more automatic process and with reduced consumption of laboratory animals. This review summarizes current trends of phage display technology with focus on the generation of hapten-specific recombinant antibodies and gives the examples of successful applications of phage display in the environmental analysis of low molecular weight compound.


1998 ◽  
Vol 4 (1) ◽  
pp. 1-20 ◽  
Author(s):  
Hennie R Hoogenboom ◽  
Adriaan P de Bruı̈ne ◽  
Simon E Hufton ◽  
René M Hoet ◽  
Jan-Willem Arends ◽  
...  

Toxins ◽  
2018 ◽  
Vol 10 (6) ◽  
pp. 236 ◽  
Author(s):  
Line Ledsgaard ◽  
Mogens Kilstrup ◽  
Aneesh Karatt-Vellatt ◽  
John McCafferty ◽  
Andreas Laustsen

2009 ◽  
Vol 26 (6) ◽  
pp. 314-321 ◽  
Author(s):  
H. Thie ◽  
S. Binius ◽  
T. Schirrmann ◽  
M. Hust ◽  
S. Dübel

Sign in / Sign up

Export Citation Format

Share Document